Mortality and Co-morbidities Among Hospitalised Hypertensives in Nigeria

Kamilu Karaye, Adeseye Akintunde, Akinsanya Olusegun-Joseph, Suleiman A Balarabe, Bolanle Okunowo, Abdulrazaq Habib, OG Opadijo


Background: The present study therefore aimed to systematically assess the co-morbidities and in-hospital outcomes among hypertensives admitted to 3 Teaching Hospitals in Nigeria.

Methods: Medical records of all subjects admitted to the medical wards of the study centres with an established diagnosis of hypertension in 2013 were reviewed.

Results: 288 hypertensive patients were consecutively admitted in the medical wards of the 3 centres in 2013, of whom 146 (59.8%) were males. 88.4% of males and 87.8% of females had 1 or more co-morbidities at admission, and the commonest among all patients was heart failure (HF) followed by stroke/transient ischemic attack (TIA), in 76 (31.2%) and 69 (28.3%) patients respectively. The most frequent co-morbidity among males was HF in 34.3% of them, while stroke/TIA was more common among female patients, in 34.7% of them. Non-cardiovascular co-morbidities were uncommon, and the most frequent was community acquired pneumonia in 7.4% of all patients. 7.8% of all patients (13 males and 6 females; p=0.427) died in-hospital. The deceased had higher Systolic Blood Pressure than the survivors, and majority of them (52.6%) were not on any antihypertensive medications at admission, which was the only predictor of mortality in the present study, increasing its odds by 7.5 fold (odds ratio=7.5; 95%confidence interval=2.8-20.0; p<0.001).

Conclusion: The most frequent co-morbidity among males was HF while stroke and TIA were most common among female patients. The prevalence of in-hospital mortality was relatively low, and not being on antihypertensive treatment at admission increased its odds by 7.5 fold.


mortality; co-morbidities; hypertension; anti-hypertensives; Nigeria

Full Text:

435 HTML


Lawes CMM, Vander Hoorn S, Rodgers A, for the International Society of Hypertension. Global burden of blood pressure related disease, 2001. Lancet 2008; 371: 1513–1518. DOI:

Adeloye D, Basquill C, Aderemi AV, Thompson JY, Obi FA. An estimate of the prevalence of hypertension in Nigeria: a systematic review and meta-analysis. J Hypertens 2015; 33(2): 230-242. DOI: 10.1097/HJH.0000000000000413

Karaye KM, Yakasai MM, Abdullahi U, Hamza M, Dalhat MM, Gwaram BA, et al. Hypertension and other cardiovascular risk factors in a semi-nomadic Fulani population in Kano, Nigeria. Nigerian Journal of Cardiology, 2015; 12(2): 124-128. DOI: 10.4103/0189-7969.152018

Kolo PM, Jibrin YB, Sanya EO, Alkali M, Peter Kio IB, Moronkola RK. Hypertension-related admissions and outcome in a tertiary hospital in northeast Nigeria. Int J Hypertens 2012; 2012: 960546. DOI: 10.1155/2012/960546.

Arodiwe EB, Ike SO, Nwokediuko SC. Case fatality among hypertension-related admissions in Enugu, Nigeria. Niger J Clin Pract 2009; 12(2): 153-156.Ukoh VA. Admission of hypertensive patients at the University of Benin Teaching Hospital, Nigeria. East Afr Med J 2007; 84(7): 329-335. DOI: 10.4314/eamj.v84i7.9588

Ukoh VA. Admission of hypertensive patients at the University of Benin Teaching Hospital, Nigeria. East Afr Med J 2007; 84(7): 329-335.

Onwuchekwa AC, Chinenye S. Clinical profile of hypertension at a University Teaching Hospital in Nigeria. Vasc Health Risk Manag 2010; 6: 511-516. DOI: 10.2147/VHRM.S10245

Karaye KM, Okeahialam BN, Wali SS. Cardiovascular risk factors in Nigerians with Systemic Hypertension. Niger J Med 2007; 16(2): 119-124.

Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312–318. DOI: 10.1161/01.STR.22.3.312

Anthony S, Kim AS, Johnston SC. Global Variation in the Relative Burden of Stroke and Ischemic Heart Disease. Circulation 2011; 124: 314-323 DOI: 10.1161/CIRCULATIONAHA.111.018820.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159-2219. DOI: 10.1001/jama.2013.284427

Joint National Committee on Prevention, detection, evaluation, and treatment of high blood pressure. The Sixth Report of the Joint National Committee (JNC-VI) on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 413-446. DOI:10.1001/archinte.1997.00440420033005

Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015; 2: 2. DOI: 10.17987/icfj.v2i1.4


Copyright (c) 2017 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.